Decreased levels of serum omentin-1 in patients with inflammatory bowel disease - sprookjes - yvandenbroek - TriplyDB

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

http://www.wikidata.org/entity/Q34982144

about

Adipokines and the role of visceral adipose tissue in inflammatory bowel disease Coronary patients with high plasma omentin are at a higher cardiovascular risk.Circulating Omentin-1 and Chronic Painful Temporomandibular Disorders Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients.Adipose Tissue-Derived Omentin-1 Function and Regulation.Omentin-A Novel Adipokine in Respiratory Diseases.Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea.

P2860

Q28070229-D5B442BA-F5F9-400D-817B-DB0608856361 Q36446038-B9E7042D-BDCA-45C9-B464-1FE93D09BE5E Q37207319-BB6882F3-269D-46E0-9E1A-C9989DE102BD Q37404766-3099390D-E098-4F35-AC46-A9E16D7BA778 Q39390964-F5BE4F81-B1FD-44F2-9E1D-B6E677780973 Q47650367-1A5F2022-CA8F-4381-8263-346904590BC9 Q47895046-E8F48F10-6348-4177-B4EC-8275F50A36D3

P2860

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

http://www.wikidata.org/entity/Q34982144

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@ast

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@en

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@nl

type

label

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@ast

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@en

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@nl

prefLabel

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@ast

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@en

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@nl

P1433

Q34982144-1AFBCC06-BECC-41DA-9C7F-35DC367DA311

P1476

Q34982144-3914EA4F-AFF3-44BF-BE7B-196A15733B7D

P2093

Q34982144-BA415C29-7C37-433C-88F7-7939B1545895

Q34982144-C22F691B-C918-44C1-B994-9FF6ADC3FD94

Q34982144-CFDB5A12-2107-4A0A-85F3-19FD7FAB4A79

Q34982144-EE0BE76D-BA6D-45FA-9BE2-44F35DC01643

P2860

Q34982144-0A1E56F6-798F-453F-AB60-6E09B11F2BB0

Q34982144-0C234249-A488-4E9B-A3A5-7082072E9F27

Q34982144-1B1EAF43-DFCB-40E0-8F9F-9AD46D31945D

Q34982144-2DB35722-0C78-4167-B2F9-91B96959EDD4

Q34982144-31A7A7B5-A295-4AB8-A2E9-3E03384E1009

Q34982144-34504192-E035-4979-992F-B0F008865D0D

Q34982144-48833890-615C-4D49-A5C5-A5EECA3DB640

Q34982144-4AD22380-43ED-4EE6-BFCB-ACCF28742B79

Q34982144-4B8719D1-C528-44CC-B05B-6040A0648BF9

Q34982144-61F49983-0F31-4038-BB0B-17BDDF730A96

P304

Q34982144-B0EB84FF-DDFE-45D4-AE04-9D4B24390BAA

P31

Q34982144-023AAF60-E3A9-48A1-B861-CA62C5E0F665

P356

Q34982144-2F6A5324-02D3-4C05-B86A-4E1588D1214B

P478

Q34982144-686C5ED4-960B-464C-B7E5-5A3452618E96

P577

Q34982144-A3737B30-AC54-4E11-9584-13386DE38A0E

P5875

Q34982144-9484EA7F-6FFB-440F-9248-0C8FB80767F6

P698

Q34982144-86CA0DA5-7AC8-4A37-9EA2-6BCB864612BB

P921

Q34982144-8956E1B4-62E0-4FAE-AA4D-4D3F8BC4FDD7

P932

Q34982144-7B9C1C50-A2C0-471A-BE6B-1506459B8310

P356

P1433

Medical Science Monitor

P1476

Decreased levels of serum omentin-1 in patients with inflammatory bowel disease

@en

P2093

Jian Yin

http://www.w3.org/2001/XMLSchema#string

Peng Hou

http://www.w3.org/2001/XMLSchema#string

Yanxiao Nie

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

Omentin: a novel link between inflammation, diabesity, and cardiovascular disease.

Study of Omentin1 and Other Adipokines and Hormones in PCOS Patients.

Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC

Endocrine and signalling role of adipose tissue: new perspectives on fat.

Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases.

Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

The fat halo sign.

A novel pathway by which the environmental toxin 4-Nonylphenol may promote an inflammatory response in inflammatory bowel disease.

P304

118-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.892081

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270827017

http://www.w3.org/2001/XMLSchema#string

P698

25576244

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

4298282

http://www.w3.org/2001/XMLSchema#string